Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse

NCT05533164 is registered in ClinicalTrials.gov with Sint Maartenskliniek as lead sponsor.

NCT NCT05533164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05533164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse
Lead sponsor
Sint Maartenskliniek
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 9, 2023
Completion date
January 31, 2028
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polymyalgia rheumatica